Boston Scientific PE Ratio 2006-2018 | BSX

Current and historical p/e ratio for Boston Scientific (BSX) from 2006 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Boston Scientific PE ratio as of October 16, 2018 is 27.42.
Boston Scientific PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2018-10-16 38.11 105.86
2018-06-30 32.70 $0.36 90.83
2018-03-31 27.32 $0.07 390.29
2017-12-31 24.79 $0.07 354.14
2017-09-30 29.17 $0.61 47.82
2017-06-30 27.72 $0.58 47.79
2017-03-31 24.87 $0.32 77.72
2016-12-31 21.63 $0.26 83.19
2016-09-30 23.80 $0.06 396.67
2016-06-30 23.37 $-0.26 0.00
2016-03-31 18.81 $-0.03 0.00
2015-12-31 18.44 $-0.18 0.00
2015-09-30 16.41 $-0.01 0.00
2015-06-30 17.70 $0.17 104.12
2015-03-31 17.75 $0.09 197.22
2014-12-31 13.25 $0.19 69.74
2014-09-30 11.81 $0.21 56.24
2014-06-30 12.77 $0.18 70.94
2014-03-31 13.52 $0.28 48.29
2013-12-31 12.02 $-0.08 0.00
2013-09-30 11.74 $-0.12 0.00
2013-06-30 9.27 $-0.64 0.00
2013-03-31 7.81 $-3.13 0.00
2012-12-31 5.73 $-2.79 0.00
2012-09-30 5.74 $-2.76 0.00
2012-06-30 5.67 $-2.15 0.00
2012-03-31 5.98 $0.34 17.59
2011-12-31 5.34 $0.27 19.78
2011-09-30 5.91 $0.35 16.89
2011-06-30 6.91 $0.38 18.18
2011-03-31 7.19 $0.34 21.15
2010-12-31 7.57 $-0.72 0.00
2010-09-30 6.13 $-1.58 0.00
2010-06-30 5.80 $-1.57 0.00
2010-03-31 7.22 $-1.53 0.00
2009-12-31 9.00 $-0.49 0.00
2009-09-30 10.59 $-1.40 0.00
2009-06-30 10.14 $-1.57 0.00
2009-03-31 7.95 $-1.60 0.00
2008-12-31 7.74 $-1.37 0.00
2008-09-30 12.27 $-0.06 0.00
2008-06-30 12.29 $-0.20 0.00
2008-03-31 12.87 $-0.19 0.00
2007-12-31 11.63 $-0.33 0.00
2007-09-30 13.95 $0.17 82.06
2007-06-30 15.34 $0.40 38.35
2007-03-31 14.54 $-2.89 0.00
2006-12-31 17.18 $-2.57 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $52.703B $9.048B
Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $130.392B 19.99
Abbott Laboratories (ABT) United States $124.469B 26.08
Stryker (SYK) United States $65.486B 25.30
Baxter (BAX) United States $38.339B 26.09
Zimmer Biomet Holdings (ZBH) United States $25.981B 16.69
ResMed (RMD) United States $15.127B 30.03
Smith & Nephew SNATS (SNN) United Kingdom $15.102B 0.00
Canopy Growth (CGC) Canada $12.198B 0.00
Perrigo (PRGO) Ireland $9.955B 14.13
Bio-Rad Laboratories (BIO) United States $8.631B 55.42
Hill-Rom Holdings (HRC) United States $5.963B 20.23
Haemonetics (HAE) United States $5.755B 52.52
ICU Medical (ICUI) United States $5.615B 38.05
Insulet (PODD) United States $5.470B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.448B 0.00
Agios Pharmaceuticals (AGIO) United States $4.104B 0.00
Hutchison China MediTech (HCM) China $3.991B 0.00
NuVasive (NUVA) United States $3.474B 32.96
Neogen (NEOG) United States $3.463B 52.44
National Vision Holdings (EYE) United States $3.208B 70.83
Quidel (QDEL) United States $2.646B 54.22
NxStage Medical (NXTM) United States $1.849B 0.00
Phibro Animal Health (PAHC) United States $1.762B 25.09
Cardiovascular Systems (CSII) United States $1.286B 740.80
AtriCure (ATRC) United States $1.116B 0.00
VAREX IMAGING (VREX) United States $1.004B 16.40
Owens & Minor (OMI) United States $0.975B 10.43
Eagle Pharmaceuticals (EGRX) United States $0.933B 27.55
Cerus (CERS) United States $0.921B 0.00
PetIQ (PETQ) United States $0.915B 29.94
OraSure Technologies (OSUR) United States $0.894B 58.48
Surmodics (SRDX) United States $0.877B 105.90
MacroGenics (MGNX) United States $0.823B 0.00
Omeros (OMER) United States $0.746B 0.00
Insys Therapeutics (INSY) United States $0.692B 0.00
Meridian Bioscience (VIVO) United States $0.657B 22.46
LeMaitre Vascular (LMAT) United States $0.556B 27.69
Lantheus Holdings (LNTH) United States $0.532B 16.52
NanoString Technologies (NSTG) United States $0.482B 0.00
TG Therapeutics (TGTX) United States $0.477B 0.00
Quanterix (QTRX) United States $0.398B 0.00
Evolus (EOLS) United States $0.374B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.356B 0.00
Cytosorbents (CTSO) United States $0.342B 0.00
Utah Medical Products (UTMD) United States $0.332B 21.38
Surface Oncology (SURF) United States $0.232B 0.00
Rockwell Medical (RMTI) United States $0.218B 0.00
BioLife Solutions (BLFS) United States $0.217B 0.00
Bovie Medical (BVX) United States $0.192B 0.00
Chimerix (CMRX) United States $0.179B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.157B 0.00
Fonar (FONR) United States $0.150B 7.42
Chembio Diagnostics (CEMI) United States $0.140B 0.00
Female Health (VERU) United States $0.080B 0.00
United-Guardian (UG) United States $0.080B 17.51
Trinity Biotech (TRIB) Ireland $0.075B 22.50
Oramed Pharmaceuticals (ORMP) Israel $0.075B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.073B 0.00
InfuSystems Holdings (INFU) United States $0.064B 0.00
CAS Medical Systems (CASM) United States $0.058B 0.00
Neurotrope (NTRP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.047B 0.00
Akers Biosciences Inc (AKER) United States $0.033B 0.00
Valeritas Holdings (VLRX) United States $0.032B 0.00
Capricor Therapeutics (CAPR) United States $0.028B 0.00
Myomo (MYO) United States $0.023B 0.00
Senestech (SNES) United States $0.017B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.016B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.010B 0.00